Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in City of Austin: The Complete Guide for Women, Families, and Survivors

For women in City of Austin who have undergone breast reconstruction, revision, or cosmetic augmentation, the expectation is always one of healing and restoration. Whether you sought care through the major medical systems serving Central Texas, such as St. David’s Medical Center, Ascension Seton, or the specialized plastic surgery centers concentrated throughout Travis County, you relied on the safety of the medical devices placed in your body. When those devices—specifically surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffolds—fail, the results are often physically devastating and emotionally isolating. At Attorney911 (The Manginello Law Firm, PLLC), we recognize that you are likely reading this while managing pain, facing the prospect of additional revision surgeries, or perhaps grappling with an oncological diagnosis like BIA-ALCL or BIA-SCC.

We built this guide to be the definitive resource for the City of Austin community. This is not merely a legal document; it is an educational foundation designed to help you understand the clinical, regulatory, and legal realities of your situation. Our Managing Partner, Ralph Manginello, is more than a board-certified-level litigator with twenty-seven years of continuous practice; he is a University of Texas at Austin alumnus who understands the specific medical landscape of City of Austin and the high standards our community expects from healthcare providers and device manufacturers alike. If you are questioning whether the complications you are enduring—from chronic redness and infection to the total failure of your reconstruction—are linked to a defective product, we are here to provide the answers that the manufacturers and, in some cases, your own surgical team may have missed.

If you have questions about what happened to your body or the devices used in your care at any City of Austin facility, we invite you to speak with us. You can reach our team at 1-888-ATTY-911 (1-888-288-9911) for a confidential, no-obligation consultation. We work on a contingency-fee basis, meaning we only recover if you do, ensuring that women in City of Austin have access to premier legal representation regardless of their current financial circumstances.

Defining the Devices: Mesh, ADM, and Resorbable Scaffolds in Breast Surgery

To handle a potential claim effectively in City of Austin’s state-law framework, you must first understand exactly what was implanted during your procedure. These products generally fall into three categories, though they are often used in similar ways, such as the “internal bra” technique designed to support a breast implant or tissue expander.

Acellular Dermal Matrix (ADM) is a biologic product derived from either human cadaver tissue (allograft) or animal tissue (xenograft, usually porcine or bovine). Examples include AlloDerm, Strattice, FlexHD, and SurgiMend. These matrices are processed to remove all cells while preserving the underlying collagen structure, supposedly allowing your own tissue to grow into the matrix over time. Bioabsorbable or resorbable scaffolds, such as GalaFLEX or Phasix, are synthetic products made from polymers like poly-4-hydroxybutyrate (P4HB). These are marketed as temporary supports that the body eventually resorbs or dissolves, typically over a window of 12 to 24 months. Finally, synthetic surgical mesh, primarily made of polypropylene, is sometimes used off-label, even though it was originally designed for hernia or pelvic repairs and was never intended for use in the delicate tissue of the breast envelope.

The core problem for many Austin patients is that none of these products were formally approved by the FDA for use in breast surgery. Instead, they entered the market through a regulatory shortcut that we will examine in detail below. If you had surgery at a high-volume center in City of Austin, your surgeon may have used these products to improve aesthetic outcomes, but frequently without adequately disclosing the risks of using devices that the FDA now explicitly warns were never tested for safety in breast tissue.

The FDA Regulatory Record: A Timeline of Failure and Warnings

For decades, device manufacturers have exploited the 510(k) clearance pathway to place products into the bodies of women in City of Austin. This pathway, authorized under 21 USC §360c and 21 CFR Part 807 Subpart E, does not require the manufacturer to prove a device is safe or effective. Instead, the manufacturer only has to show that their new device is “substantially equivalent” to a previous “predicate” device already on the market.

This system led to what experts call “predicate creep.” For instance, the manufacturer of GalaFLEX cited a surgical suture as a predicate for its breast mesh. This is a radical leap in intended use that the FDA allowed to proceed without new clinical trials. The consequences for patients in City of Austin became clear through a series of increasingly urgent FDA communications:

• July 2019: The FDA requested a global recall of Allergan BIOCELL textured breast implants after finding these devices carried a risk of BIA-ALCL six times higher than other textured implants. This recall triggered the consolidation of MDL 2921 in the District of New Jersey, where Judge Brian R. Martinotti is currently presiding over approximately 1,400 cases.
• March 2021: The FDA issued a Safety Communication regarding acellular dermal matrix products. In this brief, the agency specifically named FlexHD (MTF Biologics) and AlloMax (C.R. Bard / Becton Dickinson) as being associated with significantly higher rates of reoperation, infection, and explant when compared to other ADMs or no ADM at all.
• November 9, 2023: In a watershed letter to healthcare providers, the FDA stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” The FDA identified the entire P4HB line, including GalaFLEX and Phasix, as products requiring urgent labeling updates to reflect this lack of safety data.

For a City of Austin resident, this timeline is critical. Under Texas law, your time to file a claim—the statute of limitations—is generally two years. However, the “discovery rule” often applies, meaning the clock may not start until you discovered, or reasonably should have discovered, that the device was the cause of your harm. Many women only made this connection after the FDA’s 2023 letter was published.

Examining the Complication Spectrum: What Women in Austin Experience

Complications from these devices are rarely “random.” They are often the result of predictable biological reactions to defective materials. If you received treatment at a City of Austin facility and are experiencing any of the following, you may be the victim of a device-related injury:

Red Breast Syndrome (RBS) and Endotoxin Science

Red Breast Syndrome is a non-infectious, sterile inflammation specific to ADM. Peer-reviewed research, such as the work by Nguyen et al. (2019), has linked this to bacterial endotoxin (lipopolysaccharide) that survives the manufacturer’s sterilization process. Even if the device is technically “sterile,” the endotoxin remains biologically active, triggering chronic redness and swelling. This is a design and manufacturing failure, as switching to a different brand often resolves the issue, proving the specific device was the cause.

BIA-ALCL and BIA-SCC: The Oncological Risks

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a CD30-positive, ALK-negative T-cell lymphoma. It is not breast cancer; it is a cancer of the immune system that grows in the capsule of scar tissue around the implant. More recently, the FDA has warned of Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC), a rare and aggressive tumor. For women in City of Austin, these diagnoses require immediate and specialized surgical intervention.

Structural Failures: Capsular Contracture and Reconstruction Loss

We represent women who have suffered from Baker Grade III or IV capsular contracture—a painful hardening of the breast tissue—as well as those who have experienced “bottoming out” or skin-flap necrosis. When an ADM or scaffold like GalaFLEX fails to integrate or resorbs too quickly (or, conversely, fails to resorb on time), the entire reconstruction can fail. For many, this leads to the devastating “flat closure” outcome or requires a salvage flap procedure using tissue from the abdomen or back (DIEP or TRAM flaps).

If you are facing these trials in City of Austin, do not assume your body simply “rejected” the surgery. The device itself may have been fundamentally unfit for its intended use. Call us at 1-888-ATTY-911 for a free evaluation of your surgical records.

The Whistleblower Record: What Becton Dickinson Knew

One of the most compelling pieces of evidence in current breast mesh litigation involves Dr. Hooman Noorchashm, a cardiothoracic surgeon and former Medical Director for Becton Dickinson (BD). In 2022, Dr. Noorchashm was terminated after raising internal safety concerns regarding the P4HB scaffolds, specifically GalaFLEX.

His whistleblower allegations, filed in New Jersey under the Conscientious Employee Protection Act, are shocking. He alleges that BD withheld data from the FDA regarding breast cancer recurrences in patients who had GalaFLEX implanted. Furthermore, he contends that hundreds of Manufacturer and User Facility Device Experience (MAUDE) reports were filed with missing details that would have alerted the public to the high rates of failure. For a reconstructive patient in City of Austin, this means the very device marketed to help “restore” you after cancer may have been sold using suppressed safety data.

Product Liability and Legal Strategy: Why Your Choice of Attorney Matters

Device litigation is exceptionally complex because manufacturers often hide behind the doctrine of “federal preemption.” They argue that because the FDA cleared the device, they cannot be sued under state law. However, because these products used the 510(k) pathway rather than the more rigorous Premarket Approval (PMA) process, the Supreme Court’s decision in Medtronic v. Lohr (1996) provides a pathway for City of Austin plaintiffs to seek justice.

We focus on several key legal theories:

1. Strict Product Liability: Design defects, manufacturing defects, and failure to warn.
2. Off-Label Promotion Liability: Manufacturers who market devices for unapproved uses, such as breast surgery, can be held liable when that promotion results in foreseeable harm.
3. Breach of Warranty: Proving the device was not “fit for the particular purpose” the manufacturer claimed.
4. Negligent Credentialing: In some jurisdictions, we examine whether hospital systems in City of Austin fulfilled their duty to properly vet the products their surgeons were using.

Generalist personal-injury firms in City of Austin often miss the nuance of Buckman v. Plaintiffs’ Legal Committee (2001) or the “parallel claim” exception found in Riegel v. Medtronic (2008). Ralph Manginello’s twenty-seven years of experience and our firm’s admission to the United States District Court for the Southern District of Texas demonstrate our institutional capability to prosecute these cases against the massive legal teams of BD, Allergan, and J&J.

The Financial Reality: Verdicts and Compensation

While every case is unique, the history of mesh and implant litigation provides a framework for potential recovery. In the pelvic mesh litigation, manufacturers paid over $8 billion to settle claims for more than 100,000 women. Individual verdicts have reached $57.1 million in Philadelphia and $26.7 million in federal appellate courts. More recently, in October 2024, Becton Dickinson agreed to pay approximately $1 billion to resolve roughly 40,000 hernia mesh claims.

For women in City of Austin, damages categories include:

• Economic Damages: Costs for revision surgeries, explant procedures, hospitalization for sepsis, and lost wages while recovering.
• Non-economic Damages: Physical pain, mental anguish, permanent disfigurement, loss of breast sensation, and loss of enjoyment of life.
• Punitive Damages: In rare cases where we can prove the manufacturer acted with gross negligence or malicious concealment of safety data.

Austin residents should know that Texas has a non-economic damages cap of $250,000 for medical liability claims; however, this cap often does not apply to product liability actions against the manufacturer. We aggressively pursue every dollar you are entitled to, fighting to ensure your future medical needs are fully funded.

How to Find Answers: A Step-by-Step Guide for City of Austin Patients

If you suspect your mesh or matrix has failed, you must secure the evidence quickly. We recommend the following steps for any Austin patient:

1. Request Your Complete Operative Report: Every hospital in City of Austin is required to maintain these. Look for the “Implant Log.”
2. Identify the UDI: Secure the Unique Device Identifier or “implant stickers.” These contain the brand name, model, and lot number of the device used.
3. Preserve Explanted Devices: If you undergo a revision surgery in City of Austin, instruct your surgeon and the pathology lab in writing that you want the explanted device preserved and not destroyed. This is a critical piece of evidence.
4. Document Symptoms: Take photographs of redness, swelling, or deformity. Maintain a journal of your pain levels and any systemic symptoms (fatigue, joint pain) that may indicate breast implant illness.
5. Seek a Second Opinion: If your original City of Austin surgeon is dismissing your concerns, seek a specialist at an NCI-Designated Comprehensive Cancer Center who is experienced in reconstruction salvage.

Frequent Questions from Women in City of Austin

Is surgical mesh approved by the FDA for breast surgery?
No. As of the current date, no surgical mesh, ADM, or scaffold has been approved by the FDA for use in breast surgery. Every use of these products in a City of Austin operating room was “off-label.”

What if my surgery was years ago? Is it too late to sue?
Not necessarily. The Texas statute of limitations is generally two years from the date of discovery. If you only recently learned about the defect through an FDA notice or a diagnosis of BIA-ALCL, your time to file may have just begun. We can help you determine your specific deadline.

How do I find out which brand was used?
Your City of Austin hospital records will contain the implant stickers. If you are a patient at Seton, St. David’s, or any surgical center in Travis County, you have a legal right to these records.

What is the cost of hiring an Austin breast mesh attorney?
At Attorney911, we operate on a 100% contingency basis. There are no upfront costs, no hourly fees, and we only get paid if we win your case. We assume all the financial risk of the litigation.

Hablamos español?
Sí, hablamos español. Nuestra abogada asociada, Lupe Peña, es bilingüe y realiza consultas completas en español. No necesita un intérprete para hablar directamente con su abogado en nuestra firma.

Strategic Authority: Why Attorney911 is the Clear Choice in City of Austin

When you are fighting global corporations like Becton Dickinson (estimated 2025 revenue of over $21 billion) and AbbVie/Allergan, you need a firm with proven structural capability. We are currently lead counsel in high-profile litigation like Bermudez v. Pi Kappa Phi, where we are seeking $10,000,000 for a victim of institutional negligence. This same aggressive approach—prosecuting thirteen defendants simultaneously—is what we bring to every medical device injury case.

Ralph Manginello’s 8.2 Avvo rating and Martindale-Hubbell Preeminent status are not just awards; they are indicators of the trust peers and clients have placed in us for over a quarter of a century. We are active members of the Pro Bono College of the State Bar of Texas, proving our commitment to justice extends beyond the courtroom and into the City of Austin community we serve.

Next Steps: Restoring Your Agency and Your Rights

You are more than a patient number. Whether you were treated at an academic center like Dell Seton or a private aesthetic practice in West Lake Hills, you deserve to know the truth about the devices in your body. The path forward begins with a single conversation.

If you have experienced complications, received an Allergan recall notice, or were diagnosed with a malignancy linked to your implants, we are here to help. Reach out to the Austin team at Attorney911 by calling 1-888-ATTY-911 (1-888-288-9911). We will handle the records, the manufacturers, and the complex federal dockets, so you can focus on your recovery.

Nuestra firma está comprometida con la comunidad hispana de City of Austin. Lupe Peña y nuestro equipo bilingüe están listos para asistirla. Si usted o un ser querido ha sido lesionado por una malla mamaria defectuosa, llámenos para una consulta gratuita y confidencial en su propio idioma.

Attorney Advertising Disclaimer: This content is for educational purposes only and does not constitute legal advice. Past results, including our firm’s multimillion-dollar recoveries, do not guarantee future outcomes. No attorney-client relationship is formed until a written representation agreement is signed. The Manginello Law Firm, PLLC operates from its principal office at 1177 West Loop South, Suite 1600, Houston, TX 77027, and serves the City of Austin through its Travis County footprint.

Contact 1-888-ATTY-911 today. Your story, your health, and your justice matter to us. We serve City of Austin, Travis County, and all of Central Texas with the technical command and compassionate authority you deserve.